AzTrials
AzTrials

Very Premature BabyPIVOTNCT07903766

Effects of a Multisensory Intervention Program on the Term Behavior of the Very Premature Baby

A study testing Multisensory intervention program in people with Very Premature Baby, run by Assistance Publique Hopitaux De Marseille.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The growth and organization of the cerebral cortex is ensured by the oligodendrocyte-rich subplate, whose proper development depends on both subcortical structures and sensory experiences. Read more about this study

Who is it for?
Ages Up to 2 months
Conditions the study is for
Very Premature Baby
What is being tested?
Multisensory intervention program
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
144 participants
Where
No sites listed yet
Study dates
Jan 2027to Feb 2030
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 2 months
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • premature babies whose term of birth is between 24 and 32 weeks of amenorrhea + 6 days, and whose corrected age is between 30 and 34 weeks of amenorrhea. at the time of inclusion
  • free of neurological pathology rendering them clinically unstable, except for Papille grade 1 or 2 intraventricular hemorrhage on transfontanellar ultrasound or type 1 to 4 brain abnormalities on MRI according to the modified Paneth classification
  • with a central venous output of less than 90 cc/kg/d
  • free of infectious pathology making them clinically unstable (C-reactive protein less than 7)
  • non-intubated
  • respiratory stability at the start of CPAP weaning (at least 3 hours of room air in the last 48 hours: apnea and/or desaturation without stimulation required) or under high-flow glasses
  • no genetic syndrome, progressive neurological disease or malformation
  • whose 2 parents or legal guardians have agreed to participate and signed an informed consent form

Who cannot join

  • premature babies born at less than 24 weeks of amenorrhea and more than 32 weeks of amenorrhea + 6 days, or newborns whose corrected age is greater than 34 weeks of amenorrhea
  • with intraventricular hemorrhage grade 3 to 4 and/or MRI abnormality type 5 to 6 according to the modified Paneth classification
  • presenting a nosocomial infection
  • presenting cardio respiratory instability: continuous CPAP and intubation.
  • presenting a surgical digestive pathology or ulcerative enteritis
  • presenting a genetic syndrome, progressive neurological disease, malformative pathology or cleft lip and palate.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

About this study

Official title: Effects of a Multisensory Intervention Program Involving the Parents, From the Incubator Period, on the Term Behavior of the Very Premature Baby Born Between 24 and 32 Weeks of Amenorrhea Assessed by the NICU Network Neurobehavioral Scale (NNNS).

The growth and organization of the cerebral cortex is ensured by the oligodendrocyte-rich subplate, whose proper development depends on both subcortical structures and sensory experiences. In the incubator, the premature baby is exposed to inappropriate stimuli at a critical period of physiological immaturity and brain development. Analysis of the pathophysiological basis of neurological and behavioral disorders in premature infants highlights the interplay between biological vulnerability (cerebral alteration) and environmental factors (stress, perinatal pain and loss of emotional connection with the mother).

Developmental care aims to modify the environment in order to limit deviant developmental trajectories and reduce neurobehavioral impact, by relying on brain plasticity. This care consists of a set of environmental and behavioral strategies based on principles of balance between different stimuli adapted to cerebral maturation. The usefulness of multimodal sensory interventions as early as 28 weeks of amenorrhea has been demonstrated to offset the harmful effects of incubator dystimulation.

Read more

These interventions improve neurobehavioral disorders and reduce parental stress, but none has been shown to be superior. Welch's studies published in 2015 and 2017, based on the definition of emotional co-regulation processes, show the value of involving parents in care during hospitalization, from the incubator period onwards.

The hypothesis of this study is that multisensory intervention in a calming cycle can induce neurobehavioral improvement at term age in the very premature baby. The intervention consists of a parenting workshop and an incubator-based multisensory solicitation program with tactile, vestibular, visual and vocal contact performed by the mother or, where appropriate, the father, combined with the diffusion of maternal odor. The aim is to evaluate the effectiveness of this multisensory intervention on the behavior at term (in corrected age) of the very premature baby born between 24 and 32 weeks of amenorrhea.

Being tested
Multisensory intervention program, Standard care

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Multisensory intervention programOther

    • Training workshop for parents (information on the sensory-motor needs of premature babies, viewing of a training video, training on a neonatal dummy)
    • Multisensory incubator stimulation by the mother (or father, if applicable)
    • Mother scent diffusion, tactile and vestibular stimulation

    Gauze is placed in the mother's bra the night before each training session, and placed in a closed bag immediately after removal

  • Standard careOther

    Skin-to-skin contact, oral-facial stimulation, breastfeeding etc...

Study groups in NCT07903766
Study groupRoleWhat they receive
Experimental groupExperimentalStandard care and multisensory training
Receives: Other: Multisensory intervention program; Other: Standard care
Control groupOtherStandard care
Receives: Other: Standard care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Assessment of preterm behavior using the NICU Network Neurobehavioral Scale (NNNS) neurobehavioral scale

    The NNNS neurobehavioral scale comprises 13 dimensions: habituation (3 items rated between 1 and 9), orientation (7 items rated between 1 and 9), self-regulation (15 items rated between 1 and 9), hypertonia (10 items rated between 0 and 10), hypotonia (10 items rated between 0 and 10), asymmetry reflexes (16 items rated between 0 and 16), non-optimal reflexes (15 items rated between 0 and 15), excitability (15 items rated between 0 and 15), lethargy (15 items rated between 0 and 15), arousal (7 items rated between 1 and 9), quality of movement (6 items rated between 1 and 9), stress ( 50 items rated between 0 and 1) and handling tolerance (8 items rated between 0 and 1). This assessment is carried out at 37 weeks of amenorrhea by a trained pyschomotrician before the premature baby is discharged from hospital Higher scores reflect better neurobehavioral construction.

    Measured: 37 weeks of amenorrhea before the premature baby is discharged from hospital

Secondary outcomes (11)
  1. Average weight gain (g/kg/d)

    Measured: Day -1, at Day 1 and Day 10, at discharge and at 3 months corrected age

  2. Baby's tolerance of multi-sensory stimulation

    Simplified NIDCAP grid evaluation (Tolerance)

    Measured: days 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 of the multi-sensory stimulation

  3. Total length of hospital stay

    Number of days in hospital

    Measured: At the time of hospital discharge (up to 6 months)

  4. Duration of skin-to-skin contact per day from inclusion to incubator discharge

    Hour(s)/day of skin-to-skin contact

    Measured: during hospitalisation (up to 6 months) and at the time of hospitalisation discharge (up to 6 months)

  5. Duration of breast-feeding

    Number of days breastfeeding or bottle-feeding with breast milk

    Measured: At the time of hospital discharge (up to 6 months) and at the medical consultation at 3 months of corrected age

  6. Post-traumatic stress of mother and father

    Parents will complete the Perinatal Posttraumatic stress disorder (PPQ) questionnaire

    Measured: At the medical consultation at 3 months of corrected age

  7. Mother's and father's anxiety levels

    Anxiety symptoms will be assessed using the Spielberger scale : from a score of 20 (no anxiety) to a score of 80 (high anxiety)

    Measured: At inclusion, at the baby's discharge from hospital (up to 6 months), and at the medical consultation at 3 months of corrected

  8. Quality of life of mother and father

    Quality of life will be assessed using the questionnaire (SF 36)

    Measured: At the medical consultation at 3 months of corrected age

  9. Spontaneous motricity

    Spontaneous motricity will be assessed using the Prechtl technique via video recording

    Measured: At the medical consultation between 3 and 4 months of corrected age

  10. Staturo-ponderal growth

    Measured: During hospitalization (up to 6 months) and at the time of hospitalisation discharge (up to 6 months), then at the medical consultation at 3 months of corrected age

  11. Parent-child interaction

    Interactive Behavior coding will be carried out during breastfeeding or bottle-feeding, using a video recording

    Measured: At the medical consultation at 3 months of corrected age

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Oct 2026
  2. Study startJan 2027 (estimated)
  3. Primary completionFeb 2030 (estimated)
  4. Study completionFeb 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Sequential
Model description
Stepped-wedge
Masking
None (open label)
Enrolment
144 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07903766
Sponsor's protocol ID
RCAPHM21_0411
Acronym
PIVOT
Status last verified
Oct 2026
First submitted
15 Apr 2024
Last updated
29 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Multisensory intervention program in people with Very Premature Baby, run by Assistance Publique Hopitaux De Marseille.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 29 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Pascale CLOQUELL (0491968300, pascale.cloquell@ap-hm.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Assessment of preterm behavior using the NICU Network Neurobehavioral Scale (NNNS) neurobehavioral scale (time frame: 37 weeks of amenorrhea before the premature baby is discharged from hospital). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in